Dicerna achieves milestone in research collaboration with Kyowa Hakko
Dicerna Pharmaceuticals, a biopharmaceutical company, has reached an in vivo activity milestone in the development of its second therapeutic oncology candidate under a collaborative agreement with Kyowa Hakko
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.